Viewing Study NCT07177092


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2026-02-03 @ 4:55 AM
Study NCT ID: NCT07177092
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2025-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Primary Tumor Resection Plus Osimertinib in Advanced EGFR-mutant Non-small Cell Lung Cancer
Sponsor: Jianxing He
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
None EGFR View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small Cell Lung Cancer View
None EGFR View
None Randomized controlled trial View
None Surgery View